PT Otsuka Indonesia was established in 1974 as a joint venture pharmaceutical company with Otsuka Pharmaceutical Co., Ltd. of Japan. Its factory, built in Lawang, East Java, manufactures and markets medicinal products including Infusion/Injection Fluids, Ethical Drugs, nutritional products for special medical purposes, and medical device products. The company is recognized as a leader in the Infusion Solutions business in Indonesia, and has expanded by exporting its products to countries including Hong Kong, Singapore, Malaysia, Myanmar, Vietnam, Philippines, Mongolia, Sri Lanka, Thailand, India, and Egypt.
| Import | Export |
|---|---|
|
Trade Records
583
|
Trade Records
80
|
|
Suppliers
44
|
Buyers
11
|
|
Latest Import Date
2026-08
|
Latest Export Date
2026-08
|
According to Topease's global trade data, PT. OTSUKA INDONESIA exports products to verified importers across global markets.
Its export activity is associated with HS-code categories such as:
Representative importers include:
These export insights help users understand the PT. OTSUKA INDONESIA distribution footprint, product specialization, and shipment scale. Through Topease's deep trade data and trade intelligence capabilities—such as trade flow analysis and market benchmarking—importers and exporters can evaluate downstream demand and identify potential importer relationships.
As an importer, PT. OTSUKA INDONESIA sources products from verified exporters across multiple regions.
Its import activity spans HS-code categories including:
Representative exporters include:
These import insights help users assess sourcing patterns, supplier concentration, and trade continuity. With Topease's analytical tools—such as sourcing pattern analysis and supply-chain mapping—users can evaluate supplier performance and identify diversification opportunities.
Explore PT. OTSUKA INDONESIA's import activity, including trade volumes, top suppliers, sourcing countries, and key product categories. These insights allow exporters and potential suppliers to understand its global supply chains, track procurement trends, and identify new business opportunities.
| Exporter | Importer | HS Code | Number of Trade | Amount (USD) | Quantity | Import Port |
|---|---|---|---|---|---|---|
| BASELL ASIA PACIFIC LTD. | PT. OTSUKA INDONESIA | 3902 | 24 | $186,500 | 3,420 | Los Angeles |
| THAI OTSUKA PHARMACEUTICAL CO., LTD | PT. OTSUKA INDONESIA | 2106 | 24 | $186,500 | 3,420 | Los Angeles |
| BASELL ASIA PASIFIC LTD | PT. OTSUKA INDONESIA | 3902 | 24 | $186,500 | 3,420 | Los Angeles |
| POLYCINE GMBH | PT. OTSUKA INDONESIA | 3212 | 24 | $186,500 | 3,420 | Los Angeles |
| RENOLIT HANSEN PACKAGING TECH BJ LTD | PT. OTSUKA INDONESIA | 4014 | 24 | $186,500 | 3,420 | Los Angeles |
Gain insights into PT. OTSUKA INDONESIA's export activities, including shipment volumes, key buyers, destination countries, and product categories. Understand global demand patterns, track sales reach, and spot opportunities to connect with potential buyers.
| Importer | Exporter | HS Code | Number of Trade | Amount (USD) | Quantity | Export Port |
|---|---|---|---|---|---|---|
| OTSUKA (PHILIPPINES) PHARMACEUTICAL INC. | PT. OTSUKA INDONESIA | 3004 | 24 | $186,500 | 3,420 | Los Angeles |
| THAI OTSUKA PHARMACEUTICAL CO., LTD | PT. OTSUKA INDONESIA | 3004 | 24 | $186,500 | 3,420 | Los Angeles |
| DKSH SINGAPORE LTD | PT. OTSUKA INDONESIA | 3004 | 24 | $186,500 | 3,420 | Los Angeles |
| AYALUUN PHARM | PT. OTSUKA INDONESIA | 3004 | 24 | $186,500 | 3,420 | Los Angeles |
| OTSUKA PHARMACEUTICAL H K LTD | PT. OTSUKA INDONESIA | 3004 | 24 | $186,500 | 3,420 | Los Angeles |
Chain Insights — Explore PT. OTSUKA INDONESIA's trading network to uncover connections with international buyers and suppliers. With Topease's Supply Chain Solution, you can track product flows and identify patterns that reveal new sourcing and partnership opportunities.
Access PT. OTSUKA INDONESIA's key professional contacts for B2B outreach purposes. View verified phone numbers, emails, and LinkedIn profiles to facilitate efficient business communication.
Disclaimer: Data is compiled from public and third-party sources and may not be complete or fully accurate. This information is provided for business intelligence purposes only and should not be used for legal, financial, or compliance decisions.